Physician profile
Steven Allen
NPI 1831553346
$629.26
in general payments reported to CMS, 2019-2025
13 companies · $395 in 2025
The $395 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.76 · 2020: $30.94 · 2021: $36.33 · 2023: $48.68 · 2024: $106 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $550.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $177.04 | 2025 | |
| Steris Corporation | $89.04 | 2025 | |
| Olympus America INC. | $71.44 | 2024-2025 | Single-Use Flexible Video Bronchoscope |
| Abiomed | $47.36 | 2024 | Impella |
| Team 1, LLC | $37.39 | 2024 | |
| Insmed, INC. | $36.33 | 2021 | |
| Shionogi INC | $34.51 | 2023 | Fetroja |
| Boston Scientific Corporation | $27.36 | 2025 | Artisan |
| Merck Sharp & Dohme LLC | $26.21 | 2025 | Winrevair |
| Richard Wolf Medical Instruments Corp. | $25.71 | 2025 | |
| La Jolla Pharmaceutical Company | $22.74 | 2019-2020 | |
| Amgen INC. | $19.96 | 2020 | |
| Mylan Specialty L.P. | $14.17 | 2023 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.